Pediatrix Medical MD
$30.22 +$0.28 (+0.94%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.22 0.00%
Open$29.96
Prev close$29.94
Day range$29.89 – $30.43
Volume791.0K
Market cap$2.36B
P/E (TTM)16.5
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$501.37M+1.7% YoY
Operating profit$71.33M-3.6% YoY
Net profit$46.99M-34.5% YoY
Diluted EPS$0.59-29.8% YoY
Free cash flow$112.93M-14.4% YoY
Operating cash flow$117.31M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin26.1%
Operating margin12.1%
Net margin7.7%
Return on equity17.2%
Return on assets6.9%
Return on invested capital11.7%
Current ratio1.28
Liabilities / assets60.3%
Cash & investments$425.84M
Total debt$600.98M
Net cash (debt)-$175.14M
Free cash flow / sales10.7%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $501.37M | $487.78M | $476.20M | $1.91B | $493.77M |
| Total Operating Revenue | $501.37M | $487.78M | $476.20M | $1.91B | $493.77M |
| Cost of Revenue | $361.10M | $355.31M | $363.23M | $1.42B | $367.79M |
| Gross Profit | $140.27M | $132.47M | $112.96M | $493.70M | $125.98M |
| Operating Expense | $68.94M | $67.07M | $66.39M | $262.62M | $71.31M |
| Selling and Admin Expenses | $62.70M | $61.29M | $60.27M | $240.79M | $65.68M |
| -General & Admin Expense | $62.70M | $61.29M | $60.27M | $240.79M | $65.68M |
| Depreciation & Amortization & Depletion | $6.24M | $5.78M | $6.12M | $21.83M | $5.63M |
| -Depreciation & Amortization | $6.24M | $5.78M | $6.12M | $21.83M | $5.63M |
| Operating Profit | $71.33M | $65.40M | $46.58M | $231.09M | $54.67M |
| Net Non-Operating Interest Income (Expense) | -$8.13M | -$8.17M | -$8.27M | -$35.97M | -$8.74M |
| Non-Operating Interest Expense | $8.13M | $8.17M | $8.27M | $35.97M | $8.74M |
| Other Income (Expense) | $1.79M | -$3.23M | $530,000.00 | $21.31M | -$338,000.00 |
| Gain on Sale of Security | $5.86M | $4.55M | $4.76M | $19.05M | $4.70M |
| Earnings from Equity Interest | $2.05M | $702,000.00 | $692,000.00 | $3.63M | $843,000.00 |
| Special Income (Charges) | -$6.12M | -$8.48M | -$4.92M | -$1.37M | -$5.88M |
| -Less:Restructuring and Mergern & Acquisition | $6.12M | $8.48M | $4.92M | $22.27M | $5.88M |
| -Gain on Sale Of Business | $0.00 | – | – | $20.91M | $0.00 |
| Pretax Profit | $64.99M | $54.00M | $38.84M | $216.43M | $45.60M |
| Tax | $18.00M | $14.16M | $9.27M | $51.04M | $11.91M |
| Net Profit | $46.99M | $39.84M | $29.57M | $165.39M | $33.68M |
| Profit from Continuing Operations | $46.99M | $39.84M | $29.57M | $165.39M | $33.68M |
| Net Income to Parent Company | $46.99M | $39.84M | $29.57M | $165.39M | $33.68M |
| Net Income to Common Stockholders | $46.99M | $39.84M | $29.57M | $165.39M | $33.68M |
| Basic EPS | $0.61 | $0.50 | $0.37 | $1.97 | $0.41 |
| Diluted EPS | $0.59 | $0.49 | $0.36 | $1.94 | $0.40 |
| -Less:Impairment of Capital Assets | – | – | – | $0.00 | $0.00 |
| -Less:Write Off | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $2.14B | $2.13B | $2.07B | $2.25B | $2.25B |
| Total Current Assets | $684.08M | $660.14M | $587.03M | $763.51M | $763.51M |
| Cash and Cash Equivalents & Short-Term Investments | $425.84M | $404.20M | $328.97M | $499.72M | $499.72M |
| -Cash and Cash Equivalents | $311.92M | $288.88M | $205.78M | $375.24M | $375.24M |
| -Short Term Investments | $113.92M | $115.32M | $123.19M | $124.48M | $124.48M |
| Receivables | $240.29M | $239.01M | $236.99M | $242.31M | $242.31M |
| -Accounts Receivable | $231.82M | $227.60M | $224.80M | $229.67M | $229.67M |
| -Taxes Receivable | $8.47M | $11.40M | $12.19M | $12.64M | $12.64M |
| Prepaid Assets | $8.99M | $9.58M | $12.87M | $12.61M | $12.61M |
| Other Current Assets | $8.96M | $7.36M | $8.21M | $8.88M | $8.88M |
| Total Non-Current Assets | $1.46B | $1.47B | $1.48B | $1.48B | $1.48B |
| Net PPE | $70.95M | $73.89M | $77.97M | $73.51M | $73.51M |
| -Gross PPE | $70.95M | $73.89M | $77.97M | $205.85M | $205.85M |
| Goodwill and Other Intangible Assets | $1.28B | $1.28B | $1.28B | $1.28B | $1.28B |
| -Goodwill | $1.27B | $1.27B | $1.27B | $1.26B | $1.26B |
| -Other Intangible Assets | $13.10M | $14.51M | $15.94M | $16.86M | $16.86M |
| Non-Current Deferred Assets | $45.16M | $56.11M | $65.71M | $73.92M | $73.92M |
| Other Non-Current Assets | $57.89M | $57.43M | $55.40M | $58.16M | $58.16M |
| Total Liabilities | $1.29B | $1.25B | $1.19B | $1.38B | $1.38B |
| Total Current Liabilities | $535.73M | $501.58M | $442.64M | $458.91M | $458.91M |
| Payables | $64.61M | $60.12M | $57.43M | $77.82M | $77.82M |
| -Accounts Payable | $25.89M | $27.85M | $31.54M | $37.22M | $37.22M |
| -Total Tax Payable | $38.72M | $32.27M | $25.89M | $40.60M | $40.60M |
| Current Accrued Expenses | $280.16M | $243.04M | $180.91M | $342.69M | $342.69M |
| Short-Term Debt and Capital Lease Obligation | $190.97M | $198.42M | $204.31M | $38.40M | $38.40M |
| -Current Debt | $179.95M | $186.18M | $192.42M | $25.00M | $25.00M |
| -Current Capital Lease Obligation | $11.02M | $12.24M | $11.89M | $13.40M | $13.40M |
| Total Non-Current Liabilities | $754.07M | $747.79M | $749.08M | $921.93M | $921.93M |
| Long Term Debt and Capital Lease Obligation | $421.03M | $421.54M | $425.41M | $596.22M | $596.22M |
| -Long Term Debt | $397.77M | $398.06M | $398.35M | $568.95M | $568.95M |
| -Long Term Capital Lease Obligation | $23.26M | $23.48M | $27.06M | $27.27M | $27.27M |
| Non-Current Deferred Liabilities | $61.43M | $58.71M | $57.00M | $57.02M | $57.02M |
| Other Non-Current Liabilities | $271.61M | $267.54M | $266.67M | $268.69M | $268.69M |
| Total Equity | $849.62M | $880.98M | $878.58M | $865.85M | $865.85M |
| Stockholders' Equity | $849.62M | $880.98M | $878.58M | $865.85M | $865.85M |
| Capital Stock | $781,000.00 | $812,000.00 | $821,000.00 | $830,000.00 | $830,000.00 |
| -Common Stock | $781,000.00 | $812,000.00 | $821,000.00 | $830,000.00 | $830,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $850.57M | $894.29M | $931.26M | $947.57M | $947.57M |
| Retained Earnings | $0.00 | -$13.74M | -$53.58M | -$83.15M | -$83.15M |
| Gains/Losses Not Affecting Retained Earnings | -$1.74M | -$386,000.00 | $77,000.00 | $610,000.00 | $610,000.00 |
| -Accumulated Depreciation | – | – | – | -$132.34M | -$132.34M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $117.31M | $125.32M | -$129.85M | $271.09M | $114.10M |
| Net cash flow from continuing operations | $117.73M | $126.31M | -$129.50M | $274.74M | $114.60M |
| Net Income from Continuing Operations | $46.99M | $39.84M | $29.57M | $165.39M | $33.68M |
| Depreciation & Depletion & Amortization | $6.24M | $5.78M | $6.12M | $21.83M | $5.63M |
| Deferred Tax | $14.10M | $11.45M | $8.34M | $52.19M | $24.55M |
| Other Non-Cash Items | -$1.94M | -$613,000.00 | -$567,000.00 | -$3.63M | -$939,000.00 |
| Change in Working Capital | $46.15M | $64.78M | -$177.63M | $41.83M | $46.34M |
| -Change in Receivables | -$4.22M | -$2.80M | $4.86M | $30.56M | $1.46M |
| -Change in Prepaid Assets | -$266,000.00 | $3.93M | $34,000.00 | -$2.92M | -$2.14M |
| -Change in Payables and Accrued Expense | $46.60M | $64.64M | -$180.60M | $28.33M | $57.79M |
| -Change in Other Current Assets | $8.72M | $2.50M | $4.74M | $21.80M | $4.83M |
| -Change in Other Current Liabilities | -$4.69M | -$3.50M | -$6.68M | -$34.73M | -$14.38M |
| Cash Flow from Discontinued Operating Activities | -$420,000.00 | -$986,000.00 | -$345,000.00 | -$3.65M | -$502,000.00 |
| Net cash flow from investing | -$4.64M | $6.02M | -$11.98M | -$18.30M | -$10.28M |
| Net Cash Flow from Continuing Investing Activities | -$4.64M | $6.02M | -$11.98M | -$18.30M | -$10.28M |
| Net PPE Purchase and Sale | -$4.38M | -$1.38M | -$6.25M | -$18.46M | -$5.29M |
| Net Business Purchase and Sale | $0.00 | $0.00 | -$7.00M | $6.80M | -$4.00M |
| Net Investment Purchase and Sale | -$262,000.00 | $7.40M | $742,000.00 | -$3.18M | -$1.12M |
| Net Other Investing Changes | $0.00 | $0.00 | $526,000.00 | -$3.47M | $122,000.00 |
| Financing Cash Flow | -$89.63M | -$48.24M | -$27.64M | -$107.49M | -$68.64M |
| Net Cash Flow from Continuing Financing Activities | -$89.63M | -$48.24M | -$27.64M | -$107.49M | -$68.64M |
| Net Issuance Payments Of Debt | -$6.57M | -$6.57M | -$6.73M | -$20.75M | -$5.34M |
| Net Common Stock Issuance | -$82.36M | -$41.67M | -$20.91M | -$83.50M | -$63.39M |
| Ending Cash Balance | $311.92M | $288.88M | $205.78M | $375.24M | $375.24M |
| Net Change in Cash | $23.04M | $83.10M | -$169.46M | $145.30M | $35.18M |
| Beginning Cash Balance | $288.88M | $205.78M | $375.24M | $229.94M | $340.06M |
| Free Cash Flow | $112.93M | $123.94M | -$136.09M | $252.63M | $108.82M |
| Gain/Loss from Continuing Operations | – | – | – | -$20.91M | $0.00 |
| -Change In Other Working Capital | – | – | – | -$1.21M | – |
| Net Other Financing Charges | – | – | – | -$3.25M | $95,000.00 |
No comments yet — be the first to weigh in on MD.
Sign in to join the discussion.